Apolipoprotein Testing Market Report 2026

Apolipoprotein Testing Market Overview

• Apolipoprotein Testing market size has reached to $3.11 billion in 2025 • Expected to grow to $4.09 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: Increasing Prevalence Of Cardiovascular Diseases Is Driving The Growth Of The Apolipoprotein Testing Market • Market Trend: Advancements In Apolipoprotein Testing Enhanced Market Growth • North America was the largest region in 2025.

What Is Covered Under Apolipoprotein Testing Market?

Apolipoprotein testing refers to measuring the levels of specific apolipoproteins in the blood to assess cardiovascular risk and lipid metabolism. Apolipoprotein testing is utilized to assess an individual’s risk for cardiovascular diseases by measuring specific proteins involved in lipid metabolism. The main types of apolipoprotein for apolipoprotein testing are apolipoprotein A-I, apolipoprotein B, and apolipoprotein E. Apolipoprotein A-I is a protein that plays a crucial role in lipid metabolism. It is primarily found in high-density lipoprotein (HDL) and helps in removing excess cholesterol from the blood, reducing the risk of heart disease. It used various technologies, such as immunoassays and polymerase chain reaction (PCR), for several applications, including cardiovascular disease risk assessment, genetic testing, and others. It is used by several end-users, such as hospitals and clinics, diagnostic laboratories, and research and academic institutes.

What Is The Apolipoprotein Testing Market Growth Forecast?

The apolipoprotein testing market size is expected to see strong growth in the next few years. It will grow to $4.09 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing demand for precision cardiovascular diagnostics, rising integration of molecular diagnostics in routine testing, expansion of personalized medicine approaches, growing investments in automated diagnostic technologies, increasing focus on early disease risk stratification. Major trends in the forecast period include increasing adoption of advanced lipid risk assessment tests, rising demand for preventive cardiovascular diagnostics, growing integration of genetic and protein testing, expansion of automated immunoassay platforms, enhanced focus on personalized cardiac risk profiling.

Global Apolipoprotein Testing Market Segmentation

1) By Type Of Apolipoprotein: Apolipoprotein A-I, Apolipoprotein B, Apolipoprotein E 2) By Technology: Immunoassays, Polymerase Chain Reaction (PCR) 3) By Application: Cardiovascular Disease Risk Assessment, Genetic Testing, Other Applications 4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes Subsegments: 1) By Apolipoprotein A-I: Quantitative Testing, Qualitative Testing, Functional Testing 2) By Apolipoprotein B: Total Apolipoprotein B Testing, Apolipoprotein B100 Testing, Apolipoprotein B48 Testing 3) By Apolipoprotein E: Genotyping Tests, Protein Level Testing, Functional Assays

What Is The Driver Of The Apolipoprotein Testing Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the apolipoprotein testing market going forward. Cardiovascular disease (CVD) is a group of disorders that affect the heart and blood vessels, resulting in heart attacks, strokes, and peripheral vascular disease. The prevalence of cardiovascular disorders is rising due to several factors, such as unhealthy dietary habits, increasing obesity rates, and aging populations. Apolipoproteins, such as ApoA-I and ApoB, are crucial for lipid transport in the blood. Testing their levels helps assess cardiovascular disease risk and tailor lipid-lowering treatments for optimal management. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000, reflecting a 4.0% increase from last year's rate of 224.4 per 100,000, following a 4.6% rise in 2023, marking the first increase in these rates observed in many years. Therefore, the increasing prevalence of cardiovascular diseases drives the growth of the apolipoprotein testing industry.

Key Players In The Global Apolipoprotein Testing Market

Major companies operating in the apolipoprotein testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Bio-Rad Laboratories Inc., Randox Laboratories Ltd., R&D Systems Inc., Elabscience Bionovation Inc., Sekisui Diagnostics LLC, RayBiotech Inc., Mabtech AB, Bioss Inc., Aviva Systems Biology Corporation, Abnova Corporation, DiaSys Diagnostic Systems GmbH, Enzo Life Sciences Inc., Eagle Biosciences Inc., CLOUD-CLONE CORP., ELK Biotechnology CO. Ltd., LifeSpan BioSciences Inc.,

Global Apolipoprotein Testing Market Trends and Insights

Major companies operating in the apolipoprotein market are introducing upgraded heart health plans to provide more comprehensive assessments and personalized recommendations for managing cholesterol levels and reducing the risk of cardiovascular diseases. Enhanced heart health plans are improved wellness programs offering thorough evaluations and tailored suggestions to boost cardiovascular well-being. For instance, in January 2023, InsideTracker, a US-based personal health analysis company, introduced its Ultimate Plan to include Apolipoprotein B (ApoB) measurement, a vital indicator of heart health. This enhancement enables users to understand their cardiovascular status thoroughly, as elevated ApoB levels are associated with higher risks of atherosclerosis and heart disease. The plan offers users insights into their ApoB levels compared to standard ranges and tailored lifestyle recommendations based on extensive research by InsideTracker's science team.

What Are Latest Mergers And Acquisitions In The Apolipoprotein Testing Market?

In December 2023, Danaher Corporation, a US-based life sciences and diagnostics innovator, acquired Abcam Limited for an undisclosed amount. Through this acquisition, Danaher plans to use Abcam's cutting-edge technologies and robust market presence to boost its growth in the life sciences field. This deal is expected to enhance disease mapping and speed up drug discovery. Abcam Limited is a UK-based biotechnology company that provides an Apolipoprotein AI (APOA1) human in vitro ELISA kit.

Regional Outlook

North America was the largest region in the apolipoprotein testing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Apolipoprotein Testing Market?

The apolipoprotein testing market consists of revenues earned by entities by providing services such as monitoring lipid disorders, evaluating treatment effectiveness, and early detection of metabolic syndrome. The market value includes the value of related goods sold by the service provider or included within the service offering. The apolipoprotein testing market also includes sales of spectrophotometers, ELISA plate readers, and centrifuges. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Apolipoprotein Testing Market Report 2026?

The apolipoprotein testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the apolipoprotein testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.